Skip to main content

Table 1 Coverage of SMC defined as proportion of children who received SMC drugs at day 1 and days 1–3 according to the source of the information (interview or SMC card) during the coverage survey

From: Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali

  Interviewa SMC cardb
n/N % 95% CI n/N % 95% CI
Received at least the first day treatment of SMC at:
 Round 1 896/1170 83.7 75.6–91.9 664/766 86.7 82.0–91.3
 Round 2 903/1101 82.0 74.7–89.3 610/790 77.2 68.7–85.7
 Round 3 845/1116 75.7 67.6–83.8 523/797 65.6 55.4–75.8
 Round 4 752/1118 67.3 59.0–75.5 463/796 58.2 46.3–70.0
 Rounds 1, 2, 3 and 4 563/1046 53.8 44.5–63.1 309/760 40.7 29.2–52.1
Received all 3 days’ treatment of SMC at:
 Round 1 811/1068 75.9 67.4–84.7 – –  
 Round 2 900/1101 81.7 74.2–89.3 – –  
 Round 3 841/1116 75.4 67.3–83.4 – –  
 Round 4 747/1118 66.8 58.5–75.1 – –  
 Rounds 1, 2, 3 and 4 559/1046 53.4 44.1–62.7 – –  
  1. aBased on information from interview only
  2. bBased on information on SMC card
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us